Recon: Sanofi expects EU decision on COVID booster within weeks; FDA reviewers unconvinced ahead of second Amylyx adcomm
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy